Get 20% Free Customization In This Report

Buy this report from - $2175

Philippines Wound Care Market by Product (Advanced Wound Care, Surgical Wound Care, and Traditional/Basic Wound Care), Application (Chronic Wounds, and Acute Wounds), and End User (Hospitals, and Community Health Service Centers) - Opportunity Analysis and Industry Forecast, 2014-2022

Medical Devices & Supplies	LI_172169	Pages: 197	Apr 2017 \| 2607 Views
Author's : Amrita Srivastava & Shubangi Bawkar	Tables: 55	Charts: 60	Formats*:

Philippines Wound Care Market Overview:

Philippines Wound Care Market size was valued at $41 million in 2015, and is projected to reach $64 million by 2022, registering a CAGR of 6.4% during the forecast period. Wound care refers to specific types of treatment for pressure sores, skin ulcers and other wounds that break the skin. This can be done with the help of traditional as well as advanced wound care products. Advanced wound care is emerging as a standard solution treat chronic wounds, including pressure ulcers, diabetic foot ulcers, venous leg ulcers and arterial ulcers. Traditional wound care products are being increasingly substituted with advanced wound care products due to their efficiency and effectiveness to treat wounds thereby enabling faster healing.

The growth of the market is attributed to the rapidly ageing population & favorable demographics; rise in incidence of diabetes, obesity, and chronic conditions; technological advancements to deal with complex wounds; and increase in awareness to reduce healthcare costs. However, reluctance in adoption of new technologies restrain the growth of the market. Increased focus towards advanced treatment protocols and significant unmet needs in wound care act as the growth opportunities for the market.

Philippines Wound Care Market Segmentation

Get more information on this report : Request Sample Pages

Segment Review

Advanced wound care products have emerged as a novel approach in wound management. These advanced products promote faster healing of wounds; and hence, have been gaining an edge over traditional wound care and closure products. Continuous advancements in advanced wound care and closure products are expected to boost the market growth during the forecast period. Rising incidence of chronic wounds due to diabetes and reduced hospital stays are the key driving factors of the market. In addition, launch of wide range of products by companies to improve therapeutic outcomes has boosted the market growth.

Philippines Wound Care Market, By Product, 2015 (%)

Get more information on this report : Request Sample Pages

Wound care management finds applications in treatment of chronic as well as acute wounds. The chronic wound care is segmented into pressure ulcers, diabetic foot ulcers, venous leg ulcers, and arterial ulcers. The diabetic foot ulcer and arterial ulcer segments are attractive areas of investment in the Philippines wound care market.

Top Investment Pockets

Get more information on this report : Request Sample Pages

The list of key players profiled in the report include 3M Company, Smith & Nephew Plc., Coloplast A/S, Medtronic plc, Acelity L.P. Inc., ConvaTec Healthcare B S..r.l., Mlnlycke Health Care AB (A subsidiary of INVESTOR AB), BSN Medical GmbH, Alliqua BioMedical, Inc., Integra LifeSciences Holdings Corporation, Mundi Pharma, Bbraun, Urgo Medical, Mebo China (Mebo International Group), and Lohmann & Rauscher.

Key Benefits for Stakeholders

The report provides an in-depth analysis of the advanced wound care market across major geographies and the estimated revenues generated during the forecast period.
Quantitative analysis of the current trends and future estimations is provided to help the manufacturers of advanced wound care products to analyze the market.
The entire projections in the report are based on analysis of the current market trends and highlight the market potential for the period of 2016-2022, in terms of value.
The report conducts extensive analysis of the industry by closely following key product positioning and monitoring the top contenders within the market framework.
The report also provides quantitative and qualitative market trends to help the stakeholders to understand the situations prevailing in the market.

Philippines Wound Care Market Key Segments:

By Product

Advanced wound care
- Infection Management
  - Silver wound dressings
  - Non-silver wound dressings
  - Collagen dressings
- Exudate Management
  - Hydrocolloid dressings
  - Foam dressings
  - Alginate dressings
  - Hydrogel dressings
- Active Wound Care
  - Skin substitutes
  - Growth factors
- Therapy Devices
  - Negative pressure wound therapy (NPWT)
  - Oxygen & hyperbaric oxygen equipment
  - Electromagnetic therapy devices
  - Others
Surgical wound care
- Sutures & Staples
- Tissue Adhesives, Sealants, And Glues
  - Fibrin-Based Sealants
  - Collagen-Based Sealants
  - Synthetic Adhesives/Glues
- Anti-Infective Dressings
Traditional/Basic wound care
- Medical Tapes
- Dressings
- Cleansing Agents

By Application

Chronic wounds
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Arterial Ulcers
Acute wounds
- Burns & Trauma
  - Surgical Wounds
  - Others

By End User

Hospitals
Community Health Service Centers

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies

3.2.1.1. Competitive intelligence of companies and their strategies

3.2.2. Top investment pockets

3.3. PORTERS FIVE FORCES ANALYSIS

3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of competitive rivalry

3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Rise in geriatric population and favorable demographics
3.4.1.2. Growth in incidence of diabetes, obesity, and chronic conditions
3.4.1.3. Technological advancements to deal with complex wounds
3.4.1.4. Increase in awareness to reduce healthcare costs

3.4.2. Restraints

3.4.2.1. Reluctance in adoption of new technologies

3.4.3. Opportunities

3.4.3.1. Increase in focus towards advanced treatment protocols
3.4.3.2. Significant unmet needs in wound care

Chapter: 4 PHILIPPINES WOUND CARE MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ADVANCED WOUND CARE

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.2.3.1. Market by infection management

4.2.3.1.1. Market size and forecast

4.2.3.1.1.1. Silver wound dressings
4.2.3.1.1.2. Non-silver dressings
4.2.3.1.1.3. Collagen dressings

4.2.3.2. Market by exudate management

4.2.3.2.1. Market size and forecast

4.2.3.2.1.1. Hydrocolloid dressings
4.2.3.2.1.2. Foam dressings
4.2.3.2.1.3. Alginate dressings
4.2.3.2.1.4. Hydrogel dressings

4.2.3.3. Market by active wound care

4.2.3.3.1. Market size and forecast

4.2.3.3.1.1. Skin substitutes
4.2.3.3.1.2. Growth factors

4.2.3.4. Market by therapy device

4.2.3.4.1. Market size and forecast

4.2.3.4.1.1. Negative pressure wound therapy (NPWT)
4.2.3.4.1.2. Oxygen & hyperbaric oxygen equipment
4.2.3.4.1.3. Electromagnetic therapy devices
4.2.3.4.1.4. Others

4.3. SURGICAL WOUND CARE

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.3.3.1. Market by sutures & staples

4.3.3.1.1. Market size and forecast

4.3.3.2. Market by tissue adhesives, sealants, & glues

4.3.3.2.1. Market size and forecast

4.3.3.2.1.1. Fibrin-based sealants
4.3.3.2.1.2. Collagen-based sealants
4.3.3.2.1.3. Synthetic adhesives/glues

4.3.3.3. Market by anti-infective dressing

4.3.3.3.1. Market size and forecast

4.4. TRADITIONAL/BASIC WOUND CARE

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.4.3.1. Medical tapes

4.4.3.1.1. Market size and forecast

4.4.3.2. Dressings

4.4.3.2.1. Market size and forecast

4.4.3.3. Cleansing agents

4.4.3.3.1. Market size and forecast

Chapter: 5 PHILIPPINES WOUND CARE MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. CHRONIC WOUNDS

5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. Pressure ulcers

5.2.3.1.1. Market size and forecast

5.2.3.2. Diabetic foot ulcers

5.2.3.2.1. Market size and forecast

5.2.3.3. Venous leg ulcers

5.2.3.3.1. Market size and forecast

5.2.3.4. Arterial ulcers

5.2.3.4.1. Market size and forecast

5.3. ACUTE WOUNDS

5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. Burns & trauma

5.3.3.1.1. Market size and forecast

5.3.3.2. Surgical wounds

5.3.3.2.1. Market size and forecast

Chapter: 6 PHILIPPINES WOUND CARE MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. COMMUNITY HEALTH SERVICE CENTERS

6.3.1. Market size and forecast

Chapter: 7 PHILIPPINES WOUND CARE MARKET, BY COUNTRY

7.1. PHILIPPINES

7.1.1. Key market trends
7.1.2. Key growth factors and opportunities

Chapter: 8 COMPANY PROFILES

8.1. 3M COMPANY

8.1.1. Company overview
8.1.2. Operating business segments
8.1.3. Product portfolio
8.1.4. Business performance
8.1.5. Key strategic moves and developments

8.2. ACELITY L.P. INC.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments

8.3. ALLIQUA BIOMEDICAL, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. B. BRAUN MELSUNGEN AG

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business Performance
8.4.6. Key strategic moves and developments

8.5. BSN MEDICAL GMBH

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. COLOPLAST A/S

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments

8.7. CONVATEC HEALTHCARE B S..R.L.

8.7.1. Company overview
8.7.2. Operating business segments
8.7.3. Product portfolio
8.7.4. Business performance
8.7.5. Key strategic moves and developments

8.8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments

8.9. LOHMANN & RAUSCHER GMBH & CO. KG

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Key strategic moves and developments

8.10. MEBO CHINA (A DIVISION OF MEBO INTERNATIONAL)

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio

8.11. MEDTRONIC PLC

8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Operating business segments
8.11.4. Product portfolio
8.11.5. Business performance
8.11.6. Key strategic moves and developments

8.12. MLNLYCKE HEALTH CARE AB (A SUBSIDIARY OF INVESTOR AB)

8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Operating business segments
8.12.4. Product portfolio
8.12.5. Business performance

8.13. MUNDIPHARMA INTERNATIONAL LIMITED

8.13.1. Company overview
8.13.2. Company snapshot
8.13.3. Operating business segments
8.13.4. Product portfolio

8.14. SMITH & NEPHEW PLC

8.14.1. Company overview
8.14.2. Operating business segments
8.14.3. Product portfolio
8.14.4. Business performance
8.14.5. Key strategic moves and developments

8.15. URGO MEDICAL (A DIVISION OF URGO GROUP)

8.15.1. Company overview
8.15.2. Company snapshot
8.15.3. Operating business segments

LIST OF TABLES

TABLE 1. PHILIPPINES WOUND CARE MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 2. PHILIPPINES ADVANCED WOUND CARE MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 3. PHILIPPINES ADVANCED WOUND CARE MARKET FOR INFECTION MANAGEMENT, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 4. PHILIPPINES ADVANCED WOUND CARE MARKET FOR EXUDATE MANAGEMENT, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 5. PHILIPPINES ADVANCED WOUND CARE MARKET FOR ACTIVE WOUND CARE, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 6. PHILIPPINES ADVANCED WOUND CARE MARKET FOR THERAPY DEVICES, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 7. PHILIPPINES SURGICAL WOUND CARE MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 8. PHILIPPINES SURGICAL WOUND CARE MARKET FOR TISSUE ADHESIVES, SEALANTS, & GLUES, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 9. PHILIPPINES TRADITIONAL WOUND CARE MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 10. PHILIPPINES WOUND CARE MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 11. PHILIPPINES CHRONIC WOUND CARE MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 12. PHILIPPINES ACUTE WOUND CARE MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 13. PHILIPPINES WOUND CARE MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 14. 3M: COMPANY SNAPSHOT
TABLE 15. 3M: OPERATING SEGMENTS
TABLE 16. 3M: PRODUCT PORTFOLIO
TABLE 17. ACELITY: COMPANY SNAPSHOT
TABLE 18. ACELITY: OPERATING SEGMENTS
TABLE 19. ACELITY: PRODUCT PORTFOLIO
TABLE 20. ALLIQUA: COMPANY SNAPSHOT
TABLE 21. ALLIQUA: PRODUCT PORTFOLIO
TABLE 22. B BRAUN: COMPANY SNAPSHOT
TABLE 23. B BRAUN: OPERATING SEGMENTS
TABLE 24. B BRAUN: PRODUCT PORTFOLIO
TABLE 25. BSN MEDICAL: COMPANY SNAPSHOT
TABLE 26. BSN MEDICAL: OPERATING SEGMENTS
TABLE 27. BSN MEDICAL: PRODUCT PORTFOLIO
TABLE 28. COLOPLAST: COMPANY SNAPSHOT
TABLE 29. COLOPLAST: OPERATING SEGMENTS
TABLE 30. COLOPLAST: PRODUCT PORTFOLIO
TABLE 31. CONVATEC: COMPANY SNAPSHOT
TABLE 32. CONVATEC: OPERATING SEGMENTS
TABLE 33. CONVATEC: PRODUCT PORTFOLIO
TABLE 34. INTEGRA: COMPANY SNAPSHOT
TABLE 35. INTEGRA: OPERATING SEGMENTS
TABLE 36. INTEGRA: PRODUCT PORTFOLIO
TABLE 37. L&R: COMPANY SNAPSHOT
TABLE 38. L&R: OPERATING SEGMENTS
TABLE 39. MUNDIPHARMA: PRODUCT PORTFOLIO
TABLE 40. MEBO CHINA: COMPANY SNAPSHOT
TABLE 41. MEBO CHINA: OPERATING SEGMENTS
TABLE 42. MEBO CHINA: PRODUCT PORTFOLIO
TABLE 43. MEDTRONIC: COMPANY SNAPSHOT
TABLE 44. MEDTRONIC: OPERATING SEGMENTS
TABLE 45. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 46. MLNLYCKE: COMPANY SNAPSHOT
TABLE 47. MLNLYCKE: OPERATING SEGMENTS
TABLE 48. MLNLYCKE: PRODUCT PORTFOLIO
TABLE 49. MUNDIPHARAMA: COMPANY SNAPSHOT
TABLE 50. MUNDIPHARMA: OPERATING SEGMENTS
TABLE 51. MUNDIPHARMA: PRODUCT PORTFOLIO
TABLE 52. SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 53. SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 54. URGO MEDICAL: COMPANY SNAPSHOT
TABLE 55. URGO MEDICAL: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. PHILIPPINES WOUND CARE: MARKET SEGMENTATION
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 5. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 6. TOP INVESTMENT POCKETS IN PHILIPPINES WOUND CARE MARKET
FIGURE 7. PHILIPPINES: PROPORTIONAL MORTALITY (% OF TOTAL DEATHS, ALL AGES), 2016
FIGURE 8. PHILIPPINES WOUND CARE MARKET, BY PRODUCT, 2014-2022 ($MILLION)
FIGURE 9. PHILIPPINES ADVANCED WOUND CARE MARKET, BY PRODUCT, 2014-2022 ($MILLION)
FIGURE 10. PHILIPPINES ADVANCED WOUND CARE MARKET FOR INFECTION MANAGEMENT, BY PRODUCT, 2014-2022 ($MILLION)
FIGURE 11. PHILIPPINES ADVANCED WOUND CARE MARKET FOR EXUDATE MANAGEMENT, BY PRODUCT, 2014-2022 ($MILLION)
FIGURE 12. PHILIPPINES ADVANCED WOUND CARE MARKET FOR ACTIVE WOUND CARE, BY PRODUCT, 2014-2022 ($MILLION)
FIGURE 13. PHILIPPINES ADVANCED WOUND CARE MARKET FOR THERAPY DEVICES, BY PRODUCT, 2014-2022 ($MILLION)
FIGURE 14. PHILIPPINES SURGICAL WOUND CARE MARKET, BY PRODUCT, 2014-2022 ($MILLION)
FIGURE 15. PHILIPPINES WOUND CARE MARKET FOR SUTURES & STAPLES, 2014-2022 ($MILLION)
FIGURE 16. PHILIPPINES SURGICAL WOUND CARE MARKET FOR TISSUE ADHESIVES, SEALANTS, & GLUES, BY PRODUCT, 2014-2022 ($MILLION)
FIGURE 17. PHILIPPINES WOUND CARE MARKET FOR ANTI-INFECTIVE DRESSINGS, 2014-2022 ($MILLION)
FIGURE 18. PHILIPPINES TRADITIONAL WOUND CARE MARKET, BY PRODUCT, 2014-2022 ($MILLION)
FIGURE 19. PHILIPPINES WOUND CARE MARKET FOR MEDICAL TAPES, 2014-2022 ($MILLION)
FIGURE 20. PHILIPPINES WOUND CARE MARKET FOR DRESSINGS, 2014-2022 ($MILLION)
FIGURE 21. PHILIPPINES WOUND CARE MARKET FOR CLEANSINGS AGENTS, 2014-2022 ($MILLION)
FIGURE 22. PHILIPPINES WOUND CARE MARKET, BY APPLICATION, 2014-2022 ($MILLION)
FIGURE 23. PHILIPPINES CHRONIC WOUND CARE MARKET, BY APPLICATION, 2014-2022 ($MILLION)
FIGURE 24. PHILIPPINES CHRONIC WOUND CARE MARKET FOR PRESSURE ULCERS, 2014-2022 ($MILLION)
FIGURE 25. PHILIPPINES CHRONIC WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, 2014-2022 ($MILLION)
FIGURE 26. PHILIPPINES CHRONIC WOUND CARE MARKET FOR VENOUS LEG ULCERS, 2014-2022 ($MILLION)
FIGURE 27. PHILIPPINES CHRONIC WOUND CARE MARKET FOR ARTERIAL ULCERS, 2014-2022 ($MILLION)
FIGURE 28. PHILIPPINES ACUTE WOUND CARE MARKET, BY APPLICATION, 2014-2022 ($MILLION)
FIGURE 29. PHILIPPINES ACUTE WOUND CARE MARKET FOR BURNS & TRAUMA, 2014-2022 ($MILLION)
FIGURE 30. PHILIPPINES ACUTE WOUND CARE MARKET FOR SURGICAL WOUNDS, 2014-2022 ($MILLION)
FIGURE 31. PHILIPPINES WOUND CARE MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 32. PHILIPPINES WOUND CARE MARKET FOR HOSPITALS, 2014-2022 ($MILLION)
FIGURE 33. PHILIPPINES WOUND CARE MARKET FOR COMMUNITY HEALTH SERVICE CENTERS, 2014-2022 ($MILLION)
FIGURE 34. 3M: NET SALES, 2014-2016 ($MILLION)
FIGURE 35. 3M: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 36. 3M: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 37. ACELITY: NET REVENUE, 2013-2015 ($MILLION)
FIGURE 38. ACELITY: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 39. ACELITY: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 40. ALLIQUA: NET SALES 2014-2016 ($MILLION)
FIGURE 41. B BRAUN: NET SALES, 2014-2016 ($MILLION)
FIGURE 42. B BRAUN: REVENUE BY SEGMENT, 2016 (%)
FIGURE 43. B BRAUN: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 44. BSN MEDICAL: NET REVENUE, 2014-2016 ($MILLION)
FIGURE 45. COLOPLAST: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. COLOPLAST: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 47. COLOPLAST: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 48. CONVATEC: NET SALES, 2014-2016 ($MILLION)
FIGURE 49. CONVATEC: REVENUE BY FRANCHISE, 2016 (%)
FIGURE 50. CONVATEC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 51. INTEGRA: REVENUE, 2014-2016 ($MILLION)
FIGURE 52. INTEGRA: REVENUE BY BUSINESS SEGMENT, 2016 (%)
FIGURE 53. INTEGRA: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 54. MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 55. MEDTRONIC: REVENUE BY SEGMENT, 2016 (%)
FIGURE 56. MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 57. MLNLYCKE: NET SALES, 2014-2016 ($MILLION)
FIGURE 58. SMITH & NEPHEW: NET SALES, 2014-2016 ($MILLION)
FIGURE 59. SMITH & NEPHEW: REVENUE BY PRODUCT TYPE, 2016 (%)
FIGURE 60. SMITH & NEPHEW: REVENUE BY GEOGRAPHY, 2016 (%)

In the Philippines wound care market, utilization of surgical wound care products is expected to witness a significant rise owing to increase in prevalence of chronic diseases such as diabetes. One of major factors driving the market growth includes, better treatment option, and technological advancements especially in the advanced wound care devices segment. However, lack of reimbursement in developing regions is expected to hamper the market growth.

Presently, infection management is the most preferred option for advanced wound care in the country. Furthermore, increase in incidence of chronic wounds due to rise in geriatric population and better therapeutic outcomes of advanced wound care products boost the growth of the Philippines wound care market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Philippines Wound Care Market by Product (Advanced Wound Care, Surgical Wound Care, and Traditional/Basic Wound Care), Application (Chronic Wounds, and Acute Wounds), and End User (Hospitals, and Community Health Service Centers) - Opportunity Analysis and Industry Forecast, 2014-2022

Philippines Wound Care Market Overview: